How pediatricians in Spain manage the first acute wheezing episode in an atopic infant. Results from the TRAP study

Allergologia et Immunopathologia

Volumn 33, Issue 6, 2005, Pages 317-325

  Castro Rodriguez J A ^a   Escribano Montaner, A ^b   Garde Garde, J ^c   Morell Bernabe J J ^d   Pellegrini Belinchon J ^e   Garcia Marcos, L ^f,g  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c Allergy Section   (Spain)

^d Barcarrota Health Center   (Spain)

^e Pizarrales Health Centre   (Spain)

^f UNIVERSITY OF MURCIA   (Spain)

^g Instituto de Salud Respiratoria   (Spain)

Author keywords

Approach; Asthma; First acute wheezing episode; Management; Pediatricians

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; STEROID; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; ATOPY; CONTROLLED STUDY; FACE MASK; FOLLOW UP; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEBULIZER; PEDIATRICS; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SPAIN; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WHEEZING; ABNORMAL RESPIRATORY SOUND; ACUTE DISEASE; ASTHMA; BRONCHOSPASM; CASE MANAGEMENT; CLINICAL PRACTICE; DRUG ANTAGONISM; DRUG COMBINATION; IMMEDIATE TYPE HYPERSENSITIVITY; INFORMATION PROCESSING; INHALATION SPACER; INHALATIONAL DRUG ADMINISTRATION; MASK; METERED DOSE INHALER; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRESCHOOL CHILD; RECURRENT DISEASE; STATISTICS;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-ANTAGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL SPASM; CASE MANAGEMENT; CHILD, PRESCHOOL; DATA COLLECTION; DRUG THERAPY, COMBINATION; GUIDELINE ADHERENCE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFANT; INHALATION SPACERS; MASKS; METERED DOSE INHALERS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; QUESTIONNAIRES; RECEPTORS, ADRENERGIC, BETA-2; RECURRENCE; RESPIRATORY SOUNDS; SPAIN;

EID: 33646854731     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/S0301-0546(05)73250-X     Document Type: Article

References (28)

1. Garde Garde JM, Muñoz Lopez F, Fernández Benítez M, Lucas Giralt C. Guía para la atención del niño asmático. Protocolo diagnóstico y terapéutico del asma infantil. Allergol et Immunopathol. 2000; Suppl. 1:7-54.
2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. National Institutes of Health National Heart, Lung, and Blood Institute 2002; Bethseda (Maryland, USA).
3. Guidelines for the diagnosis and management of asthma. Update on selected topics-2002. National Institutes of Health National Heart, Lung, and Blood Institute National asthma education and prevention program 2002; Bethseda (Maryland, USA): (NIH Publication No. 02-5075).
4. Warner JO, Naspitz CK. Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol. 1998;25:1-17.
5. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-6.
6. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133-8.
7. Sporik R, Holgate ST, Cogswell JJ. Natural history of asthma in childhood-a birth cohort study. Arch Dis Child. 1991;66:1050-3.
8. Lewiston NJ. What is wheezy bronchitis? Pediatr Ann. 1989;18:792-8.
9. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986;2:1424-5.
10. Lenney W, Milner AD. At what age do bronchodilator drugs work? Arch Dis Child. 1978;53:532-5.
11. Lenney W, Evans NA. Nebulized salbutamol and ipratropium bromide in asthmatic children. Br J Dis Chest. 1986;80:59-65.
12. Kraemer R, Frey U, Sommer CW, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis. 1991;144:347-51.
13. Yuksel B, Greenough A. Effect of nebulized salbutamol in preterm infants during the first year of life. Eur Respir J. 1991;4:1088-92.
14. Mallol J, Barrueto L, Girardi G, Toro O. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device. Pediatr Pulmonol. 1987;3:352-6.
15. Rubilar L, Castro-Rodriguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol. 2000;29:264-9.
16. Mandelberg A, Tsehori S, Houri S, Gilad E, Morag B, Priel IE. Is nebulized aerosol treatment necessary in the pediatric emergency department? Chest. 2000;117(5):1309-3.
17. Closa RM, Ceballos JM, Gomez-Papi A, Galiana AS, Gutierrez C, Marti-Henneber C. Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol. 1998;26:344-8.
18. Daugbjerg P, Brenoe E, Forchhammer H, Frederiksen B, Glazowski MJ, Ibsen KK, et al. A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr. 1993;82:547-51.
19. British guideline on the management of asthma. Thorax. 2003;58 Suppl 1:1-94.
20. Aguinaga O, I, Arnedo PA, Bellido J, Guillen Grima F, Suarez-Varela MM. Prevalencia de síntomas relacionados con el asma en niños de 13-14 años de 9 poblaciones españolas. Grupo Español del estudio ISAAC (International Study of Asthma and Allergies in Childhood). Med Clin (Barc). 1999;112:171-5.
21. Edmonds ML, Camargo CA, Jr., Brenner BE, Rowe BH. Replacement of Oral Corticosteroids With Inhaled Corticosteroids in the Treatment of Acute Asthma Following Emergency Department Discharge: A Meta-analysis. Chest. 2002;121:1798-805.
22. Jones TV, Gerrity MS, Earp J. Written case simulations: do they predict physicians' behavior? J Clin Epidemiol. 1990;43:805-15.
23. Warner JO. Review of prescribed treatment for children with asthma in 1990. BMJ. 1995;311:663-6.
24. Maziak W, von Mutius E, Beimfohr C, Hirsch T, Leupold W, Keil U, et al. The management of childhood asthma in the community. Eur Respir J. 2002;20(6):1476-82.
25. Neville RG, Hoskins G, Smith B, Clark RA. How general practitioners manage acute asthma attacks. Thorax. 1997;52:153-6.
26. Finkelstein JA, Lozano P, Shulruff R, Inui TS, Soumerai SB, Ng M, et al. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics. 2000;106 Suppl 4:886-96.
27. Vichyanond P, Hatchaleelaha S, Jintavorn V, Kerdsomnuig S. How pediatricians manage asthma in Thailand. Pediatr Pulmonol. 2001;32:109-14.
28. Garcia-Marcos L, Schuster A. Antileukotrienes in asthma: present situation. Expert Opin Pharmacother. 2001;2:441-66.